ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

EW Edwards Lifesciences Corp

87.00
-0.86 (-0.98%)
Jun 04 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,825,440
Bid Price
Ask Price
News -
Day High 88.14

Low
60.57

52 Week Range

High
96.12

Day Low 86.95
Share Name Share Symbol Market Stock Type
Edwards Lifesciences Corp EW NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
-0.86 -0.98% 87.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
87.92 86.95 88.14 87.41 87.86
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
31,075 1,825,440 US$ 87.52 US$ 159,759,185 - 60.57 - 96.12
Last Trade Type Quantity Price Currency
18:52:24 10 US$ 87.50 USD

Edwards Lifesciences Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
52.52B 601.30M - 6B 1.4B 2.33 37.45
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Edwards Lifesciences News

Date Time Source News Article
6/03/202405:38Edgar (US Regulatory)Form 8-K - Current report
6/03/202405:30PR Newswire (US)BD to Acquire Edwards Lifesciences' Critical Care Product..
5/30/202416:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/30/202415:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/30/202415:08Edgar (US Regulatory)Form SD - Specialized disclosure report
5/21/202416:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/13/202416:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/13/202416:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/13/202416:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/13/202416:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/13/202416:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EW Message Board. Create One! See More Posts on EW Message Board See More Message Board Posts

Historical EW Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week87.8088.85585.7987.282,844,372-0.80-0.91%
1 Month85.6091.9484.6787.792,416,2981.401.64%
3 Months90.5896.1283.5089.922,982,761-3.58-3.95%
6 Months68.3696.1266.8683.453,731,99218.6427.27%
1 Year84.9496.1260.5779.423,716,1972.062.43%
3 Years94.76131.7360.5788.713,233,807-7.76-8.19%
5 Years170.44248.5060.5799.652,732,541-83.44-48.96%

Edwards Lifesciences Description

Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology serving patients in 100+ countries with the help of our employees in areas including Clinical Affairs Quality Engineering Research & Development Regulatory Affairs Sales & Marketing corporate functions and more. Our roots date back to 1958 when Miles Lowell Edwards a retired engineer with a background in hydraulics and fuel pump operations set out to build the first artificial heart. Edwards believed the heart could be mechanized and was encouraged by Dr. Albert Starr to focus on developing an artificial heart valve. After just two years the first Starr-Edwards mitral valve was developed and successfully placed in a patient. This innovation spawned Edwards Laboratories.